The shares were down 15% after disappointing earnings, although revenue growth was very brisk and the shares quickly recovered. The 2019 revenue guidance is disappointing, but there is the potential […]
The shares have fallen back over 50% of their summer heights. What’s going on? Q3 revenues were off only fractionally, but revenue growth slowed down quite a bit sequentially and […]
The shares of IntriCon have gone parabolic, and it’s not hard to see why. The main driver is the rapid increase in sales to Medtronic’s continuing glucose monitoring systems, and […]